Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Comparison of Combination Chemotherapy Regimens in Treating Patients With Advanced Stomach Cancer

ClinicalTrials.gov ID: NCT00003172

Public ClinicalTrials.gov record NCT00003172. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 25, 2026, 1:18 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized Phase II Trial of Either 5-Fluorouracil, Recombinant Alfa-2a-Interferon and Intravenous Hydroxyurea With Filgrastim Support (FHIG) or Doxorubicin/Docetaxel (Dd) in Patients With Advanced Gastric Cancer

Study identification

NCT ID
NCT00003172
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Eastern Cooperative Oncology Group
Network
Enrollment
Not listed

Conditions and interventions

Conditions

Interventions

  • filgrastim Biological
  • recombinant interferon alfa Biological
  • docetaxel Drug
  • doxorubicin hydrochloride Drug
  • fluorouracil Drug
  • hydroxyurea Drug

Biological · Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 1997
Primary completion
Not listed
Completion
Aug 31, 2004
Last update posted
Jun 20, 2013

1997 – 2004

United States locations

U.S. sites
24
U.S. states
14
U.S. cities
21
Facility City State ZIP Site status
CCOP - Colorado Cancer Research Program, Inc. Denver Colorado 80209-5031
Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago Illinois 60611
Veterans Affairs Medical Center - Chicago (Lakeside) Chicago Illinois 60611
CCOP - Illinois Oncology Research Association Peoria Illinois 61602
CCOP - Central Illinois Springfield Illinois 62526
CCOP - Cedar Rapids Oncology Project Cedar Rapids Iowa 52403-1206
CCOP - Ochsner New Orleans Louisiana 70121
New England Medical Center Hospital Boston Massachusetts 02111
CCOP - Kalamazoo Kalamazoo Michigan 49007-3731
CCOP - Metro-Minnesota Saint Louis Park Minnesota 55416
CCOP - Missouri Valley Cancer Consortium Omaha Nebraska 68131
Veterans Affairs Medical Center - East Orange East Orange New Jersey 07018-1095
CCOP - Northern New Jersey Hackensack New Jersey 07601
University of Rochester Cancer Center Rochester New York 14642
Albert Einstein Comprehensive Cancer Center The Bronx New York 10461
Ireland Cancer Center Cleveland Ohio 44106-5065
CCOP - St. Francis Hospital/Natalie Warren Bryant Cancer Center Tulsa Oklahoma 74136
Allegheny University Hospitals- Hahnemann Philadelphia Pennsylvania 19102-1192
University of Pennsylvania Cancer Center Philadelphia Pennsylvania 19104
University of Pittsburgh Cancer Institute Pittsburgh Pennsylvania 15213
CCOP - MainLine Health Wynnewood Pennsylvania 19096
Veterans Affairs Medical Center - Madison Madison Wisconsin 53705
University of Wisconsin Comprehensive Cancer Center Madison Wisconsin 53792
CCOP - Marshfield Medical Research and Education Foundation Marshfield Wisconsin 54449

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00003172, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 20, 2013 · Synced Jun 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00003172 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →